sciencemag : The DEA to change key marijuana research rules
DEA verdict on marijuana research draws mixed reaction
Frustrating those wishing to study its medical potential, marijuana will remain a Schedule I substance, the most tightly regulated class of drugs in the United States.The announcement today by the Drug Enforcement Administration (DEA) keeps marijuana in the same class as heroin, LSD, and other potentially dangerous or highly addictive drugs and comes as a disappointment to U.S. researchers who have argued that looser restrictions are needed to facilitate studies on whether cannabis can treat conditions ranging from chronic pain to brain tumors to childhood epilepsy.There was a glimmer of good news for those scientists in the DEA announcement, though.
read more from here
The DEA to change key marijuana research rules
The Drug Enforcement Agency signaled on Thursday that it plans a dramatic shift in the way the United States conducts research on marijuana.The move is expected to significantly expand both the scope and specificity of scientific study on the drug.In a statement touting “several marijuana- related actions,” the DEA announced that the University of Mississippi will no longer be the sole licensed grower of research marijuana in the country.
read more from here
DEA rejects marijuana reclassification, despite states’ shifting acceptance
The US Drug Enforcement Administration said marijuana would remain in the restrictive Schedule I on Thursday, but signaled support for expanding medical research.At 400-years old, could this shark be the longest living vertebrate?Medical marijuana grows at Jeff Smith’s and Cassie Heckenkamp’s property along the McKenzie River east of Springfield, Ore., in June.
read more from here
